When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...

Sam Altman has unveiled an AI-focused initiative under OpenAI Foundation to revolutionize healthcare, aiming to expedite ...

The field of chronic disease management is witnessing a significant transformation due to recent advancements in big data analytics and artificial intelligence (AI). Major chronic diseases, such as ...

The last couple of decades has seen increased attention by scientists and medical researchers on drug repurposing and the ...

Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...